C12N 2501/2305
Interleukin-5
Official title: Interleukin-5 (IL-5)
C12N2501/2305 (Interleukin-5) appears on 10 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 23
- Assignees
- 18
- Inventors
- 77
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 4 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 2 | 4 |
| 2025 | 1 | 2 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Culture medium and method for inducing iPSC differentiation to obtain macrophages and use thereof26 Aug 2025US 12,398,370 B2Allife Medicine (Beijing) Limited
- Growth and survival compositions for cells capable of producing antibodies and methods related thereto24 Dec 2024US 12,173,315 B2Emory University
- Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells13 Feb 2024US 11,896,614 B2Novartis AG
- Methods for generating functional therapeutic B cells ex-vivo12 Sep 2023US 11,753,624 B2Georgia Tech Research Corporation
- Growth and survival compositions for cells capable of producing antibodies and methods related thereto21 Sep 2021US 11,124,766 B2Emory University
- Biomarkers related to immunotherapy efficacy6 Aug 2026US 2026/0224626 A1Kite Pharma, Inc.
- In vitro cultivation method for antibody expressing cells16 Jul 2026US 2026/0201327 A1Roche Diagnostics Operations, Inc.
- Method for the production of gamma delta t cells for immunotherapy applications9 Jul 2026US 2026/0193608 A1Ji Yan Biomedical Co., Ltd.
- Method for in vitro large-scale expansion of double-negative t cells rich in tscm and tcm16 Apr 2026US 2026/0102491 A1Ruichuang Biotech.Co., Ltd.
- Recombinant production of growth factors in algae for cell culture applications27 Nov 2025US 2025/0361278 A1Phycin Inc.
Most cited
By later US patents
- Material and methods for the growth of hematopoietic stem cells15US 7,790,458 B2Becton, Dickinson and Company · 2010
- NKT-like cell subpopulation and method of using the same in the treatment of tumor1US 10,149,863 B2Tsinghua University · 2018
- Growth and survival compositions for cells capable of producing antibodies and methods related thereto1US 11,124,766 B2Emory University · 2021
- Cd4+ Cd25+ T-cells activated to a specific antigen1US 8,785,140 B2New South Innovations Pty Limited · 2014